MUTANTS OF HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) AND USES THEREOF

Details for Australian Patent Application No. 2002357896 (hide)

Owner THE GOVERNMENT OF THE UNITED STATES OF AMERICA represented by The Secretary, Department of Health

Inventors RECHLER, Mathew, M.

Pub. Number AU-A-2002357896

PCT Number PCT/US02/40561

PCT Pub. Number WO2003/052079

Priority 60/341,920 17.12.01 US

Filing date 17 December 2002

Wipo publication date 30 June 2003

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/341,920 17.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002357896

6 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357897-METHOD AND APPARATUS FOR REMOVING TRAPPED WATER

2002357895-HYBRID ARCHITECTURE FOR SUPPORTING LOCAL DETERMINATION IN A WIRELESS NETWORK